Document Detail


Rituximab-induced vasculitis: A case report and review of the medical published work.
MedLine Citation:
PMID:  19382999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rituximab is an anti-CD20 chimeric murine/human monoclonal antibody mainly used in the treatment of patients with a cutaneous lymphoid malignancy. Among the side-effects associated with rituximab administration, vasculitis has been rarely reported. There are two reported cases in the English language medical published work. We describe a 38-year-old Korean man with cutaneous vasculitis occurring 1 day after rituximab administration.
Authors:
Min Joo Kim; Hyung Ok Kim; Ho Yeon Kim; Young Min Park
Related Documents :
19933019 - Dermatofibrosarcoma protuberans with contiguous infiltration of the underlying bone.
20683369 - Melanocytic nevi of the tarsal conjunctiva: clinicopathologic case series with review o...
2332829 - Management of complex pedal cutaneous larva migrans.
2576949 - Cutaneous lichen amyloidosis associated with multiple endocrine neoplasia type 2a.
12950339 - Haemorrhagic bullae in a case of paroxysmal nocturnal haemoglobinuria.
12876489 - Old world cutaneous leishmaniasis in los angeles: a case report, overview of the curren...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  The Journal of dermatology     Volume:  36     ISSN:  1346-8138     ISO Abbreviation:  J. Dermatol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-22     Completed Date:  2009-07-24     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7600545     Medline TA:  J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  284-7     Citation Subset:  IM    
Affiliation:
Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antibodies, Monoclonal / adverse effects*
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Humans
Male
Skin / pathology
Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*,  pathology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antirheumatic Agents; 0/rituximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Severity factors of Mamushi (Agkistrodon blomhoffii) bite.
Next Document:  Autosomal recessive type 2 pseudoxanthoma elasticum presenting with generalized skin laxity.